Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GSK Consent Decree Includes $650 Mil. Bond, Third-Party Inspections

May 02 2005

• By The Tan Sheet

Related Content

FDA Seizure Of GSK Products Exemplifies Heightened Warning Letter Gravitas

Apr 04 2005

Schering Claritin Awaits FDA Certification; Correctol SKUs To Be Discontinued

May 20 2002

Additional Topics

OTC Drugs Consumer

More from Archive

More from HBW Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window